NYSE:EW | Free Cash Flow | Edwards Lifesciences Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2008-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$43.8M$64.9M-$21.1M-5.54%
2025-12-31$450.9M$97.4M$353.5M387.61%
2025-03-31$280.4M$56M$224.4M62.68%
2024-12-31-$127.5M$49.8M-$177.3M-45.98%
2024-03-31-$53.5M$65.3M-$118.8M-33.76%
2023-12-31$136.6M$88.3M$48.3M13.06%
2023-03-31$314.1M$61.5M$252.6M74.19%
2022-12-31$282.8M$68.9M$213.9M53.69%
2022-03-31$293.3M$72.7M$220.6M59.05%
2021-12-31$373.6M$89.8M$283.8M
2021-03-31$300.5M$106M$194.5M
2020-12-31$399.8M$113.2M$286.6M
2020-03-31$207.1M$82.2M$124.9M
2019-12-31$402.9M$71.5M$331.4M
2019-03-31$1.5M$42.2M-$40.7M
2018-12-31$292.9M$57.6M$235.3M
2018-03-31$151.3M$43.2M$108.1M
2017-12-31$363.9M$51.9M$312M
2017-03-31$128.3M$15.9M$112.4M
2016-12-31$201.1M$63.2M$137.9M
2016-03-31$107.1M$27.7M$79.4M
2015-12-31$103.8M$37.5M$66.3M
2015-03-31$73.3M$20.8M$52.5M
2014-12-31$93.2M$34.5M$58.7M
2014-03-31$138.9M$14.3M$124.6M
2013-12-31$111.3M$20.1M$91.2M
2013-03-31$101.1M$36.8M$64.3M
2012-12-31$114.7M$44.1M$70.6M
2012-03-31-$30.7M$18M-$48.7M
2011-12-31$93.4M$26M$67.4M
2011-03-31$14.9M$13.9M$1M1.56%
2010-12-31$94M$21.7M$72.3M111.57%
2010-03-31$13M$8M$5M10.48%
2009-12-31$65.9M$23.7M$42.2M88.66%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$1.6B$260.2M$1.34B124.36%
2024-12-31$542.3M$252.4M$289.9M6.94%
2023-12-31$895.8M$253M$642.8M45.84%
2022-12-31$1.22B$244.6M$973.6M63.97%
2021-12-31$1.73B$325.8M$1.41B93.56%
2020-12-31$1.05B$407M$647.3M
2019-12-31$1.18B$254.4M$928.5M
2018-12-31$926.7M$238.7M$688M
2017-12-31$1B$168.1M$832.6M
2016-12-31$704.4M$176.1M$528.3M
2015-12-31$549.7M$102.7M$447M
2014-12-31$1.02B$82.9M$939.4M
2013-12-31$472.7M$109M$363.7M
2012-12-31$362.1M$109M$253.1M
2011-12-31$308.2M$76.6M$231.6M
2010-12-31$251.4M$61.8M$189.6M86.97%
2009-12-31$165.3M$64M$101.3M44.22%
2008-12-31$153.2M$50.6M$102.6M79.60%